Related Experiment Video
Updated: Oct 13, 2025

Loss-of-Function Approach in the Embryonic Chick Retina by Using Tol2 Transposon-Mediated Transgenic Expression of Artificial microRNAs
Published on: May 18, 2022
Maternally expressed gene 3 regulates retinal neovascularization in retinopathy of prematurity
Yu Di1, Yue Wang1, Yue-Xia Wang1
1Department of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
Abstract:
The mouse model of oxygen induced retinopathy is suitable for the study of various retinal neovascularization diseases, including retinopathy of prematurity. The maternally expressed gene 3 (MEG3) has been demonstrated to have an inhibitory effect on diabetic retinopathy. In this study, we investigated the role of MEG3 overexpression in oxygen-induced retinopathy in mice. The results showed that MEG3 overexpression effectively inhibited the production of retinal neovascularization in oxygen-induced retinopathy mice. It acts by down-regulating the expression of phosphoinositide 3-kinase, serine/threonine kinase, and vascular endothelial growth factor and pro-inflammatory factors. MEG3 overexpression lentivirus has a future as a new method for the clinical treatment of retinopathy of prematurity. The animal experiments were approved by the Animal Ethics Committee of Shengjing Hospital of China Medical University, China (approval No. 2016PS074K) on February 25, 2016.
Insights
Maternally expressed gene 3 (MEG3) overexpression inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy. This finding suggests MEG3 lentivirus could treat retinopathy of prematurity.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Oxygen-induced retinopathy (OIR) mouse model is crucial for studying retinal neovascularization diseases like retinopathy of prematurity.
- Maternally expressed gene 3 (MEG3) shows inhibitory effects in diabetic retinopathy.
Purpose of the Study:
- To investigate the role and mechanism of MEG3 overexpression in OIR mice.
- To evaluate the potential of MEG3 lentivirus for treating retinopathy of prematurity.
Main Methods:
- Establishing an oxygen-induced retinopathy mouse model.
- Overexpressing MEG3 using lentivirus in OIR mice.
- Analyzing the expression of key signaling molecules and inflammatory factors.
Main Results:
- MEG3 overexpression significantly inhibited retinal neovascularization in OIR mice.
- MEG3 down-regulated the expression of phosphoinositide 3-kinase, serine/threonine kinase, vascular endothelial growth factor, and pro-inflammatory factors.
- MEG3 overexpression demonstrated therapeutic potential in the OIR model.
Conclusions:
- MEG3 overexpression effectively suppresses retinal neovascularization in OIR by modulating specific molecular pathways.
- MEG3 lentivirus represents a promising therapeutic strategy for retinopathy of prematurity.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Regulation of Angiogenesis and Blood Supply

